title: Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.
abstract: The BOB.1/OBF.1/OCAB.1 protein is a lymphocyte-specific transcriptional coactivator. It interacts with the Oct1 and Oct2 transcription factors and contributes to the transcriptional activity of octamer motifs. The analysis of established B cell lines had suggested that BOB.1/OBF.1 is constitutively expressed at all stages of B cell development. Here we show that expression of BOB. 1/OBF.1 is regulated within the B cell lineage. Specifically, germinal center B cells show highly increased BOB.1/OBF.1 levels. We can induce the up-regulation by stimulating primary splenic B cells, eg, by triggering CD40 signaling in the presence of interleukin-4. Expression of BOB.1/OBF.1 is detectable but reduced in spleens from mice unable to undergo the germinal center reaction due to mutations in the TNF receptor p55 or lymphotoxin beta (LTbeta) receptor genes. Furthermore, we demonstrate that BOB.1/OBF.1 expression is highly regulated in human B cell lymphomas. Whereas lymphomas representing pre- and postfollicular B cell developmental stages are negative for BOB.1/OBF.1, high-level expression of BOB.1/OBF.1 is characteristic of germinal center-derived tumors. In these tumors BOB.1/OBF.1 is typically coexpressed with high levels of Bcl6. These results imply that overexpression of BOB.1/OBF.1, like overexpression of Bcl6, might play a role in the pathogenesis of germinal center-derived B cell lymphomas. Furthermore, overexpression of BOB.1/OBF.1 represents a characteristic feature of these tumors that is useful in their identification.
authors.affiliation: Pathologisches Institut, Würzburg. Würzburg. München, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Greiner
authors.forename: K B
authors.initials: KB
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Hess
authors.forename: K
authors.initials: K
authors.lastname: Pfeffer
authors.forename: H K
authors.initials: HK
authors.lastname: Müller-Hermelink
authors.forename: T
authors.initials: T
authors.lastname: Wirth
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics; D001402:B-Lymphocytes / Q000378:metabolism* / Q000473:pathology / Q000502:physiology; D002454:Cell Differentiation; D002460:Cell Line; D016922:Cellular Senescence / Q000502:physiology; D018858:Germinal Center / Q000378:metabolism*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism* / Q000473:pathology; D053259:Lymphotoxin beta Receptor; D051379:Mice; D009154:Mutation; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics; D047888:Receptors, Tumor Necrosis Factor, Type I; D012016:Reference Values; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D015534:Trans-Activators / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D015703:Antigens, CD; C505697:LTBR protein, human; C505699:Ltbr protein, mouse; D053259:Lymphotoxin beta Receptor; C091546:POU2AF1 protein, human; C490424:Pou2af1 protein, mouse; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D015534:Trans-Activators